News from Nashville & around the world
by Bill Snyder AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. On Oct. 9, AstraZeneca…
The number of active COVID-19 cases in Tennessee is rising. In the 13 counties that comprise the Nashville Metropolitan Area, new cases have increased 50% over the last 2 weeks. We strongly urge everyone…
by Bill Snyder Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19. The…
by Bill Snyder The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) held its third annual symposium last week as a virtual, online event to preserve social distancing during COVID-19. VI4 Director Eric Skaar, PhD,…
Vanderbilt University has been searching for a new chancellor since Nicholas S. Zeppos stepped down in August. GANNETT Syndication Service
